Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy K Starr

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Human Molecular Genetics|January 18, 2025
Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancerAnna Prizment, Abby Standafer, Conghui Qu, et al.
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Hepatology Communications|November 9, 2019
R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent MannerCaitlin B Conboy, Germán L Vélez-Reyes, Barbara R Tschida, et al.
The Journal of Experimental Medicine|September 2, 2020
APOBEC3A catalyzes mutation and drives carcinogenesis in vivoEmily K Law, Rena Levin-Klein, Matthew C Jarvis, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post ChemotherapyBoris J N Winterhoff, Nomeda Girnius, Muyi Liu, et al.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
Nature|August 17, 2012
Recurrent R-spondin fusions in colon cancerSomasekar Seshagiri, Eric W Stawiski, Steffen Durinck, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Cell|February 16, 2024
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancerShrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell|August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancerShrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Human Molecular Genetics|January 18, 2025
Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancerAnna Prizment, Abby Standafer, Conghui Qu, et al.
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Hepatology Communications|November 9, 2019
R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent MannerCaitlin B Conboy, Germán L Vélez-Reyes, Barbara R Tschida, et al.
The Journal of Experimental Medicine|September 2, 2020
APOBEC3A catalyzes mutation and drives carcinogenesis in vivoEmily K Law, Rena Levin-Klein, Matthew C Jarvis, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post ChemotherapyBoris J N Winterhoff, Nomeda Girnius, Muyi Liu, et al.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
Nature|August 17, 2012
Recurrent R-spondin fusions in colon cancerSomasekar Seshagiri, Eric W Stawiski, Steffen Durinck, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Cell|February 16, 2024
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancerShrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell|August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancerShrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Pageof 6